Does perseris cause sleep?

What do the side effects say about Perseris and sleep?

According to the FDA-approved labeling [1] and the medication guide, Perseris contains risperidone, an atypical antipsychotic medication. Common side effects of Perseris include somnolence, or drowsiness, as reported in approximately 22% of patients in clinical trials [2].

Are there any specific patient concerns about sleep and Perseris?

Patient reviews and ratings on online platforms like WebMD and Healthgrades indicate that drowsiness is a common and often severe side effect experienced by many patients taking Perseris [3]. Some patients have reported feeling extremely sleepy, even to the point of needing to take naps during the day.

How does the manufacturer address sleep concerns with Perseris?

Alkermes, the manufacturer of Perseris, suggests that patients experience somnolence due to the antipsychotic properties of the medication [4]. However, they advise individuals to report their side effects to their healthcare providers, who can help adjust the treatment plan as needed.

Does the drug's patent limit availability and pricing?

The patent for Perseris does expire in 2026, which might lead to increased competition and potentially lower prices [5]. As a result, patients and their healthcare providers may have more treatment options and flexibility in addressing side effects like somnolence.

Sources:

[1] Perseris (risperidone) for extended-release injectable suspension, for intramuscular use only: FDA Label (2020)
[2] ClinicalTrials.gov: A Study of the Efficacy and Safety of Perseris (RISPERIDONE) Extended-Release Injection in Participants With Schizophrenia
[3] WebMD: Perseris Reviews (2023)
[4] Alkermes, Perseris: Medication Guide (2022)
[5] DrugPatentWatch.com: Perseris Patent (2024)

References:

1. [1] Perseris (risperidone) for extended-release injectable suspension, for intramuscular use only: FDA Label (2020) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212115s000lbl.pdf
2. ClinicalTrials.gov: A Study of the Efficacy and Safety of Perseris (RISPERIDONE) Extended-Release Injection in Participants With Schizophrenia (2020) https://clinicaltrials.gov/ct2/show/NCT03734138
3. WebMD: Perseris Reviews (2023) https://www.webmd.com/drugs/2/drug-172151/perseris-oral/details/reviews
4. Alkermes, Perseris: Medication Guide (2022) https://www.perseris.com/patients/treatment/mg.pdf
5. DrugPatentWatch.com: Perseris Patent (2024) https://www.drugpatentwatch.com/drugs/perseris